The role of microRNAs in the idiopathic inflammatory myopathies

Current Opinion in Rheumatology

Volumn 27, Issue 6, 2015, Pages 608-615

  Parkes, Joanna E ^a   Day, Philip J ^a   Chinoy, Hector ^a   Lamb, Janine A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Autoimmune; Biomarker; Idiopathic inflammatory myopathies; MicroRNA; Muscle

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 146A; MICRORNA 155; MICRORNA 223; MICRORNA 7; PROTEIN KINASE C EPSILON; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; DERMATOMYOSITIS; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; JUVENILE DERMATOMYOSITIS; KERATINOCYTE; MUSCLE DEVELOPMENT; MYOBLAST; MYOSITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; BLOOD; IMMUNOLOGY; MUSCLE ATROPHY; MUSCLE WEAKNESS;

AUTOIMMUNITY; BIOMARKERS; HUMANS; MICRORNAS; MUSCLE WEAKNESS; MUSCULAR ATROPHY; MYOSITIS;

EID: 84942526043     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000225     Document Type: Article

References (41)

1. Zeng L, Cui J, Wu H, et al. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity 2014; 47:419-429.
2. Saito Y, Saito H, Liang G, et al. Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol 2014; 47:128-135.
3. Saba R, Sorensen DL, Booth Sa. MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol 2014; 5:578-588.
4. Van Rooij E, Liu N, Olson EN. MicroRNAs flex their muscles. Trends Genet 2008; 24:159-166.
5. Güller I, Russell AP. MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. J Physiol 2010; 588:4075-4087.
6. Chen J-F, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38:228-233.
7. Chen J-F, Tao Y, Li J, et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 2010; 190:867-879.
8. Eisenberg I, Eran A, Nishino I, et al. Distinctive patterns of microRNA expression in primary muscular disorders. PNAS 2007; 104:17016-17021.
9. Wang Y-Z, Tian F-F, Yan M, et al. Delivery of an miR155 inhibitor by anti-CD20 single-chain antibody into B cells reduces the acetylcholine receptor-specific autoantibodies and ameliorates experimental autoimmune myasthenia gravis. Clin Exp Immunol 2014; 176:207-221.
10. Sun X, Sit A, Feinberg MW. Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med 2014; 24:105-112.
11. Georgantas RW, Streicher K, Greenberg Sa, et al. Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies. Arthritis Rheumatol (Hoboken, NJ) 2014; 66:1022-1033.
12. Zhu W, Streicher K, Shen N, et al. Genomic signatures characterize leukocyte infiltration in myositis muscles. BMC Med Genomics 2012; 5:53-64.
13. Pandis I, Ospelt C, Karagianni N, et al. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann Rheum Dis 2012; 71:1716-1723.
14. Shimada S, Jinnin M, Ogata A, et al. Serum miR-21 levels in patients with dermatomyositis. Clin Exp Rheumatol 2013; 31:161-162.
15. Pan W, Zhu S, Yuan M, et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010; 184:6773-6781.
16. Okada Y, Jinnin M, Makino T, et al. MIRSNP rs2910164 of miR-146a is associated with the muscle involvement in polymyositis /dermatomyositis. Int J Dermatol 2014; 53:300-304.
17. Tang X, Tian X, Zhang Y, et al. Correlation between the frequency of Th17 cell and the expression of microRNA-206 in patients with dermatomyositis. Clin Dev Immunol 2013; 2013:345347.
18. Inoue K, Jinnin M, Yamane K, et al. Down-regulation of miR-223 contributes to the formation of Gottron's papules in dermatomyositis via the induction of PKCe. Eur J Dermatol 2013; 23:160-168.
19. Oshikawa Y, Jinnin M, Makino T, et al. Decreased miR-7 expression in the skin and sera of patients with dermatomyositis. Acta Derm Venereol 2013; 93:273-276.
20. Kim E, Cook-Mills J, Morgan G, et al. Increased expression of vascular cell adhesion molecule 1 in muscle biopsy samples from juvenile dermatomyositis patients with short duration of untreated disease is regulated by miR-126. Arthritis Rheum 2012; 64:3809-3817.
21. Li C, Fu W, Zhang Y, et al. Meta-analysis of microRNA-146a rs2910164 G>C polymorphism association with autoimmune diseases susceptibility: an update based on 24 studies. PLoS One 2015; 10:1-12.
22. Iaccarino L, Ghirardello A, Bettio S, et al. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun 2014; 48-49:122-127.
23. Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013; 13:666-678.
24. Lin C-C, Sharma SB, Farrugia MK, et al. Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival. Oncogenesis 2015; 4:e155.
25. Broen JCa, Radstake TRDJ, Rossato M. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis. Nat Rev Rheumatol 2014; 10:1-11.
26. Xia J, Zhang W. MicroRNAs in normal and psoriatic skin. Physiol Genomics 2014; 46:113-122.
27. Taïbi F, Metzinger-Le Meuth V, Massy Za, et al. MiR-223: an inflammatory oncomiR enters the cardiovascular field. Biochim Biophys Acta Mol Basis Dis 2014; 1842:1001-1009.
28. Haneklaus M, Gerlic M, O'Neill LaJ, et al. MiR-223: infection, inflammation and cancer. J Intern Med 2013; 274:215-226.
29. Olazagasti JM, Baez PJ, Wetter Da, et al. Cancer risk in dermatomyositis: a meta-analysis of cohort studies. Am J Clin Dermatol 2015; 16:89-98.
30. Milisenda JC, Selva-O'Callaghan A, Grau JM. The diagnosis and classification of polymyositis. J Autoimmun 2014; 48-49:118-121.
31. Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006.
32. Ashby J, Flack K, Jimenez LA, et al. Distribution profiling of circulating microRNAs in serum. Anal Chem 2014; 86:9343-9349.
33. Xu L, Li M, Wang M, et al. The expression of microRNA-375 in plasma and tissue is matched in human colorectal cancer. BMC Cancer 2014; 14:714-724.
34. Cheng L, Sun X, Scicluna BJ, et al. Characterization and deep sequencing analysis of exosomal and nonexosomal miRNA in human urine. Kidney Int 2014; 86:433-444.
35. De Jong YP, Jacobson IM. Antisense therapy for hepatitis C virus infection. J Hepatol 2014; 60:227-228.
36. Jackson AL, Levin Aa. Developing microRNA therapeutics: approaching the unique complexities. Nucleic Acid Ther 2012; 22:213-225.
37. Liu AM, Poon RTP, Luk JM. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun 2010; 394:623-627.
38. De Souza Rocha Simonini P, Breiling A, Gupta N, et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010; 70:9175-9184.
39. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007; 21:1025-1030.
40. Reinhart BJ, Slack FJ, Basson M. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Lett Nat 2000; 403:901-906.
41. Sokol NS, Xu P, Jan Y-N, et al. Drosophila let-7 microRNA is required for remodeling of the neuromusculature during metamorphosis. Genes Dev 2008; 22:1591-1596.